Zevia PBC (ZVIA) stock
Close on Oct 30, 2026Market cap $92.04MP/E –Yield –
Earnings
Zevia PBC's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Zevia PBC's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026during market hours | $45.00M | +1.1% | -$0.04 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026during market hours | $46.09M | +21.3% | -$0.03 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026during market hours | $37.90M | -4.1% | -$0.02 | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025during market hours | $40.80M | +12.1% | -$0.04 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025during market hours | $44.50M | +10.1% | -$0.01 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025during market hours | $38.00M | -2.1% | -$0.08 | -$3.30 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | $39.50M | +4.5% | -$0.09 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024before the open | $36.40M | -15.5% | -$0.04 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024before the open | $40.40M | -4.3% | -$0.10 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024before the open | $38.80M | -10.4% | -$0.10 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024before the open | $37.80M | +6.8% | -$0.14 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023before the open | $43.10M | -2.5% | -$0.16 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | $42.20M | -7.3% | -$0.08 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023before the open | $43.30M | +13.9% | -$0.04 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023before the open | $35.40M | +3.5% | -$0.10 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | $44.20M | +13.3% | -$0.17 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022before the open | $45.50M | – | -$0.28 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022before the open | $38.00M | – | -$0.30 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022before the open | $34.20M | – | -$0.59 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | $39.00M | – | -$0.75 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Zevia PBC's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net sales | Q3 FY2026 | $44.00M – $46.00M | – | New | Aug 5, 2026 |
| adjusted EBITDA lossnon-GAAP | Q3 FY2026 | -$3.50M – -$3.00M | – | New | Aug 5, 2026 |
| net sales | FY2026 | $170.00M – $175.00M | $170.00M – $175.00M | Reaffirmed | Aug 5, 2026 |
| adjusted EBITDA lossnon-GAAP | FY2026 | -$4.00M – -$2.00M | -$4.00M – -$2.00M | Reaffirmed | Aug 5, 2026 |
Guidance vs results
The last range Zevia PBC gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $43.00M – $45.00M | $45.00M | Within range |
| Q1 FY2026 | Revenue | $40.00M – $42.00M | $46.09M | Above range |
| FY2025 | Revenue | $162.00M – $164.00M | $161.20MΣ4Q | Below range |
| Q4 FY2025 | Revenue | $39.00M – $41.00M | $37.90M | Below range |
| Q3 FY2025 | Revenue | $38.00M – $40.00M | $40.80M | Above range |
| Q2 FY2025 | Revenue | $40.50M – $42.50M | $44.50M | Above range |
| Q1 FY2025 | Revenue | $36.00M – $38.00M | $38.00M | Within range |
| Q4 FY2024 | Revenue | $39.50M | $39.50M | Within range |
| Q3 FY2024 | Revenue | $37.00M – $40.00M | $36.40M | Below range |
| Q2 FY2024 | Revenue | $38.00M – $40.00M | $40.40M | Above range |
| Q1 FY2024 | Revenue | $38.00M – $40.00M | $38.80M | Within range |
| Q4 FY2023 | Revenue | $36.00M – $39.00M | $37.80M | Within range |
| Q3 FY2023 | Revenue | $38.00M – $41.00M | $43.10M | Above range |
| Q2 FY2023 | Revenue | $48.00M – $51.00M | $42.20M | Below range |
| Q1 FY2023 | Revenue | $40.00M – $43.00M | $43.30M | Above range |
| Q4 FY2022 | Revenue | $30.00M – $32.00M | $35.40M | Above range |
| Q3 FY2022 | Revenue | $46.00M – $48.00M | $44.20M | Below range |
| Q2 FY2022 | Revenue | $41.00M – $43.00M | $45.50M | Above range |
| Q1 FY2022 | Revenue | $36.00M – $38.00M | $38.00M | Within range |
Guidance history
Every forecast Zevia PBC put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 5, 2026 | adjusted EBITDA loss | Q3 FY2026 | -$3.50M – -$3.00M | New |
| Aug 5, 2026 | adjusted EBITDA loss | FY2026 | -$4.00M – -$2.00M | Reaffirmed |
| Aug 5, 2026 | net sales | Q3 FY2026 | $44.00M – $46.00M | New |
| Aug 5, 2026 | net sales | FY2026 | $170.00M – $175.00M | Reaffirmed |
| May 6, 2026 | adjusted EBITDA loss | Q2 FY2026 | -$1.00M – -$500.00K | New |
| May 6, 2026 | adjusted EBITDA loss | FY2026 | -$4.00M – -$2.00M | Lowered |
| May 6, 2026 | net sales | FY2026 | $170.00M – $175.00M | Raised |
| May 6, 2026 | net sales | Q2 FY2026 | $43.00M – $45.00M | New |
| Feb 25, 2026 | adjusted EBITDA | Q1 FY2026 | -$1.90M – -$1.60M | New |
| Feb 25, 2026 | adjusted EBITDA | FY2026 | -$1.00M – $500.00K | New |
| Feb 25, 2026 | net sales | FY2026 | $169.00M – $173.00M | New |
| Feb 25, 2026 | net sales | Q1 FY2026 | $40.00M – $42.00M | New |
| Nov 5, 2025 | adjusted EBITDA loss | Q4 FY2025 | -$750.00K – -$250.00K | New |
| Nov 5, 2025 | Adjusted EBITDA loss | FY2025 | -$5.50M – -$5.00M | New |
| Nov 5, 2025 | net sales | Q4 FY2025 | $39.00M – $41.00M | New |
| Nov 5, 2025 | net sales | FY2025 | $162.00M – $164.00M | New |
| Aug 6, 2025 | Adjusted EBITDA loss | FY2025 | -$9.00M – -$7.00M | Raised |
| Aug 6, 2025 | adjusted EBITDA loss | Q3 FY2025 | -$3.90M – -$3.40M | New |
| Aug 6, 2025 | net sales | FY2025 | $158.00M – $163.00M | Reaffirmed |
| Aug 6, 2025 | net sales | Q3 FY2025 | $38.00M – $40.00M | New |
| May 7, 2025 | adjusted EBITDA loss | FY2025 | -$11.00M – -$8.00M | Lowered |
| May 7, 2025 | adjusted EBITDA loss | Q2 FY2025 | -$2.90M – -$2.20M | New |
| May 7, 2025 | net sales | FY2025 | $158.00M – $163.00M | Reaffirmed |
| May 7, 2025 | net sales | Q2 FY2025 | $40.50M – $42.50M | New |
| Feb 26, 2025 | adjusted EBITDA loss | FY2025 | $8.00M – $11.00M | New |
| Feb 26, 2025 | adjusted EBITDA loss | Q1 FY2025 | $5.60M – $6.00M | New |
| Feb 26, 2025 | net sales | FY2025 | $158.00M – $163.00M | New |
| Feb 26, 2025 | net sales | Q1 FY2025 | $36.00M – $38.00M | New |
| Jan 13, 2025 | Adjusted EBITDA loss | Q4 FY2024 | -$4.20M – -$3.90M | Lowered |
| Jan 13, 2025 | Adjusted EBITDA loss | FY2024 | -$15.50M – -$15.20M | New |
| Jan 13, 2025 | Net sales | FY2024 | $155.00M | Narrowed |
| Jan 13, 2025 | Net sales | Q4 FY2024 | $39.50M | Narrowed |
| Nov 6, 2024 | Adjusted EBITDA losses | Q4 FY2024 | $1.80M – $2.20M | New |
| Nov 6, 2024 | Net sales | Q4 FY2024 | $38.00M – $40.00M | New |
| Nov 6, 2024 | Net sales | FY2024 | $154.00M – $156.00M | Lowered |
| Aug 7, 2024 | net sales | FY2024 | $158.00M – $166.00M | Reaffirmed |
| Aug 7, 2024 | net sales | Q3 FY2024 | $37.00M – $40.00M | New |
| May 8, 2024 | net sales | Q2 FY2024 | $38.00M – $40.00M | New |
| May 8, 2024 | net sales | FY2024 | $158.00M – $166.00M | New |
| Feb 27, 2024 | net sales | Q1 FY2024 | $38.00M – $40.00M | New |
| Nov 7, 2023 | net sales | FY2023 | $165.00M – $168.00M | Lowered |
| Nov 7, 2023 | net sales | Q4 FY2023 | $36.00M – $39.00M | New |
| Aug 8, 2023 | net sales | FY2023 | $163.00M – $168.00M | New |
| Aug 8, 2023 | net sales | Q3 FY2023 | $38.00M – $41.00M | New |
| May 9, 2023 | net sales | FY2023 | $180.00M – $190.00M | Reaffirmed |
| May 9, 2023 | net sales | Q2 FY2023 | $48.00M – $51.00M | New |
| Feb 28, 2023 | net sales | FY2023 | $180.00M – $190.00M | New |
| Feb 28, 2023 | net sales | Q1 FY2023 | $40.00M – $43.00M | New |
| Nov 10, 2022 | Net sales | FY2022 | $158.00M – $160.00M | New |
| Nov 10, 2022 | net sales | Q4 FY2022 | $30.00M – $32.00M | New |
| Aug 11, 2022 | net sales | FY2022 | $177.00M – $182.00M | Reaffirmed |
| Aug 11, 2022 | net sales | Q3 FY2022 | $46.00M – $48.00M | New |
| May 12, 2022 | net sales | FY2022 | $177.00M – $182.00M | Reaffirmed |
| May 12, 2022 | net sales | Q2 FY2022 | $41.00M – $43.00M | New |
| Feb 24, 2022 | net sales | FY2022 | $177.00M – $182.00M | New |
| Feb 24, 2022 | net sales | Q1 FY2022 | $36.00M – $38.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Zevia PBC filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- News
- Update